Image-Based Cytometer Market Size, Share, And Trends Analysis Report By Application (Research, Clinical, Others) By End-User (Hospitals, Commercial Organizations, Clinical Testing Labs, Others) Based On Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 529 | Number of pages: 197 | Published Date: Jan 2022

    Published | Category: Medical Device | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Image-Based Cytometer Market Size, Share, And Trends Analysis Report By Application (Research, Clinical, Others) By End-User (Hospitals, Commercial Organizations, Clinical Testing Labs, Others) Based On Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Image-Based Cytometer Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028. The rising trend towards precision medicine, increasing use of image-based cytometers in clinical trials and growing technological advancements are some factors driving the growth of the market.

Image-Based Cytometer Market is valued at USD 89.0 Million in 2021 and is expected to reach USD 110.3 Million by 2028 with a CAGR of 2.7% over the forecast period.

Market Analysis of Image-Based Cytometer:-

Image-based cytometry, also called microfluidic image cytometry, is a technique that combines the power of imaging analysis and the advantage of microfluidics. Microfluidic tools provide distinct advantages of precise control and manipulation of fluids in a sub microliter volume, which makes the sample consumption down to 1000-2800 cells for each assay. Such low sample/reagent consumption, cost efficiency, as well as high-throughput make image cytometry a perfect fit for rare sample clinical analysis. The use of image-based cytometers in the clinical laboratory has grown substantially in the past decade. This is attributable in part to the development of smaller, user-friendly, less-expensive instruments and a continuous increase in the number of clinical applications.

Image-Based Cytometer market report is segmented on the basis of application, end-users and regional & country level. Based upon application, the global image-based cytometer market is classified into research, clinical, and others. Based upon end-users, the global image-based cytometer market is classified into hospitals, commercial organizations, clinical testing labs, and others.

The regions covered in this image-based cytometer market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of image-based cytometer is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Image-Based Cytometer Companies

Global image-based cytometer market report covers prominent players like Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation, Thorlabs, Inc. and among others.

Image Based Cytometer Market

Image-Based Cytometer Market Segmentation Analysis:-

By Application:

  • Research
  • Clinical
  • Others

By End-User:

  • Hospitals
  • Commercial Organizations
  • Clinical Testing Labs
  • Others

Market Dynamics:-

The increasing demand for image-based cytometers is owing to technological advancements, the increasing use of image-based cytometers in clinical trials, the development of in-built software, and the growing utilization of image-based flow cytometers in research activities. For instance; The Jefferson Trust awarded USD 775,000 to universities to engage faculty and students in research. Additionally, Mass Cytometry Antibody Bank was awarded USD 35,000, for new technology which simultaneously measures 100 different cellular attributes of thousands of individual cells. However, the major hurdle for the researchers to access such technologies is the high cost related to buying antibodies. Through this funding, this hurdle was overcome and could act as support for future donations. Moreover, rapid ‘user? friendly’ systems currently under development may increase the market growth opportunity of image-based cytometric systems.

Regional Analysis:-

North America is estimated to remain the dominating region due to well-known advancements in the research and development field along with elevated technological developments in this region. The World Health Organization(WHO) classification for tumors of the hematopoietic and lymphoid tissues defines many of these entities and has been widely adopted. This classification endorses a multiparametric approach to diagnosis with the identification of morphologic, phenotypic, and genotypic features that are characteristic of each disease entity. While Asia Pacific is expected to emerge as the fastest-growing region due to growing expenditure by the government on R&D activities as well as rising technological advancements in the developed and developing countries of this region. These factors are expected to drive the demand for the image-based cytometer market in this region.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2021: USD 89.0 Million 
Base year considered 2020
Forecast Period CAGR %:

2.7% 

Market Size Expected in 2028: USD 110.3 Million 
Tables, Charts & Figures: 175
Pages 200
Image-Based Cytometer Companies Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation, Thorlabs, Inc. and among others.
Segments Covered By Application, By End-User
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Image-Based Cytometer Report–

  • Global Image-Based Cytometer report covers in-depth historical and forecast analysis.
  • Global Image-Based Cytometer research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Image-Based Cytometer Market report helps to identify opportunities in the marketplace.
  • Global Image-Based Cytometer Market report covers an extensive analysis of emerging trends and competitive landscape.

On Special Requirements Image-Based Cytometer Market Report is also available for the below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

The Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA


Frequently Asked Questions (FAQ) :
Image-Based Cytometer Market is valued at USD 89.0 Million in 2021
The Image-Based Cytometer Market Size is Projected to Reach USD 110.3 Million By 2028 at a CAGR 2.7%
Rising trend towards precision medicine, increasing use of image-based cytometers in clinical trials and growing technological advancements are some factors driving the growth of the market.
Invitrogen, ChemoMetec A/S, Nexcelom Bioscience LLC., Vala Sciences Inc., Merck KGaA, GE Healthcare, Yokogawa Electric Corporation, Thorlabs, Inc. and among others.
North America is estimated to remain the dominating region due to well-known advancements in the research and development field along with elevated technological developments in this region.



Interested in this report?

Image-Based Cytometer Market Size, Share, Growth, And Industry Analysis By 2028

report cover

Image-Based Cytometer Market Size, Share, And Trends Analysis Report By Application (Research, Clinical, Others) By End-User (Hospitals, Commercial Organizations, Clinical Testing Labs, Others) Based On Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?